Donor Multi TAA-Specific T Cells (ADSPAM)

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donor Multi TAA-Specific T Cells (ADSPAM), covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM) [Phase 1]